| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 08/26/2009 | EP1207879B1 Nicotine receptor agonists in stem cell and progenitor cell recruitment |
| 08/26/2009 | EP1061812B1 Food products having enhanced cocoa polyphenol content and processes for producing same |
| 08/26/2009 | CN101517081A RNAi-mediated inhibition of Gremlin for treatment of IOP-related conditions |
| 08/26/2009 | CN101517075A Cell death inducer |
| 08/26/2009 | CN101516833A Tartrate derivatives for use as coagulation factor IXa inhibitors |
| 08/26/2009 | CN101516385A Treatment of excessive neovascularization |
| 08/26/2009 | CN101514234A Blackfungus polyhexose extraction method |
| 08/26/2009 | CN101514231A Fusion protein for resisting formation of thrombus targetedly and preparation method and application thereof |
| 08/26/2009 | CN101514225A Self-polymerization polypeptide and preparation method and application thereof |
| 08/26/2009 | CN101514179A Indolone hydrazine ethylidene carbonyl compound, method for preparing same and application thereof in medicine |
| 08/26/2009 | CN101513504A Chinese herbal medicine for remedying thrombocytopenia after radiochemotherapy |
| 08/26/2009 | CN101513496A Medicine for treating epistaxis |
| 08/26/2009 | CN101513452A Decumbent corydalis tuber cataplasm and preparation method thereof |
| 08/26/2009 | CN101513438A Method for extracting panax notoginseng saponins from fresh panax notoginsengs |
| 08/26/2009 | CN101513187A O,O-methylethyl-O-(1-phenyl-1,2,4-triazole-3-group)thiophosphate organophosphorus insecticidal acaricide |
| 08/26/2009 | CN100532387C Novel compound neopuerarin A and its separating method |
| 08/26/2009 | CN100531802C Pseudo-type retrovirus vector containing membrane protein having hemagglutinin activity |
| 08/26/2009 | CN100531797C Novel use of erythropoietin in heart diseases |
| 08/26/2009 | CN100531789C Chinese medicine for treating injury |
| 08/26/2009 | CN100531750C Use of red sage root extract in preparing antithrombotic pharmaceutical composition |
| 08/26/2009 | CN100531587C A processing method of ginkgo flower tea |
| 08/25/2009 | US7579357 Antidiabetic agents; obesity; controlling appetite |
| 08/25/2009 | US7579354 3-[4-(2,6-Dioxo-1,3-dipropyl-2,3,6,7-tetrahydro- 1H-purin-8-yl)- bicyclo[2.2.2]oct-1-yl]-propionic acid or pharmaceutically acceptable salts; highly potent and selective diuretics; treatment of cardiac and circulatory disorders, degenerative disorders of central nervous system |
| 08/25/2009 | US7579346 Carboxamides |
| 08/25/2009 | US7579342 Pteridine compounds for the treatment of psoriasis |
| 08/25/2009 | US7579331 Method of improved diuresis in individuals with impaired renal function |
| 08/25/2009 | US7579170 Method for preparing monoclonal antibodies capable of activating effector cells expressing FCγRIII |
| 08/25/2009 | US7579001 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders |
| 08/25/2009 | CA2634663C Novel albumin-free factor viii formulations |
| 08/25/2009 | CA2538072C Amide-type carboxamide derivatives |
| 08/25/2009 | CA2474578C Novel pyridin- and pyrimidin-derivatives |
| 08/25/2009 | CA2405172C Alpha,beta-unsaturated sulfones for treating proliferative disorders |
| 08/25/2009 | CA2394794C Methods for preparing pharmaceutical formulations |
| 08/25/2009 | CA2269246C Substituted tricyclics |
| 08/25/2009 | CA2099541C Cyclic adhesion inhibitors |
| 08/25/2009 | CA2088889C Specific antibodies against activated platelets, the preparation thereof and the use thereof in diagnosis and therapy |
| 08/20/2009 | WO2009102191A1 Health supplement composition of sea cucumber |
| 08/20/2009 | WO2009100955A1 Antisense rna targeting cxcr4 |
| 08/20/2009 | WO2009100592A1 Preparation of rupatadine or it's salts |
| 08/20/2009 | WO2009068214A3 Heteroaryl-substituted piperidines |
| 08/20/2009 | US20090209747 Method to inhibit cell growth using oligonucleotides |
| 08/20/2009 | US20090209658 Embolic compositions |
| 08/20/2009 | US20090209614 administering glutamine or glutamine chloride to a patient for increasing blood flow in in the capillary vessels; treating a condition selected from dementia, cold constitution, shoulder stiffness, skin muddiness, muscle fatigue, impaired liver function, lowered immunity |
| 08/20/2009 | US20090209576 Pharmaceutical composition containing clopidogrel camphorsulfonate or polymorphic forms thereof |
| 08/20/2009 | US20090209570 6-Aminomorphinane Derivatives, Method for the Production and Use Thereof |
| 08/20/2009 | US20090209511 Benzofuran Derivatives |
| 08/20/2009 | US20090209478 Compositions and methods for inhibiting expression of the hamp gene |
| 08/20/2009 | US20090209457 Treatment of anti-erythropoietin antibody-mediated disorders with synthetic peptide-based epo receptor agonists |
| 08/20/2009 | US20090208512 Catalytic anti-factor VIII allo-antibodies |
| 08/20/2009 | US20090208504 Polypeptides involved in immune response |
| 08/20/2009 | US20090208467 P27 and p21 in gene therapies |
| 08/20/2009 | US20090208459 Methods of treating anemia using recombinant adeno-associated virus virions |
| 08/19/2009 | EP2090589A1 Albumin-fused Kunitz domain peptides |
| 08/19/2009 | EP2090300A1 Sustained release preparation |
| 08/19/2009 | EP2090177A1 Food products having enhanced cocoa polyphenol content |
| 08/19/2009 | EP2089058A2 Methods of treating hemolytic anemia |
| 08/19/2009 | EP2089047A2 Compositions and methods for cardiac tissue protection and regeneration |
| 08/19/2009 | EP2089041A2 Methods for using aldhbr cells to supplement stem cell transplantation |
| 08/19/2009 | EP1691827B1 Use of peptides derived from the b beta chain of human fibronogen for the treatment of shock |
| 08/19/2009 | EP1287349B1 Method and apparatus for monitoring anti-platelet agents |
| 08/19/2009 | EP1194167B1 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 08/19/2009 | EP1078003B1 Plasmin inhibitors from the australian brown snake, pseudonaja textilis textilis |
| 08/19/2009 | CN101511852A Synthesis of diethyl{ i5'' (3 -fluorophenyl) -pyridine-2-yl] methyl} phosphonate used in the synthesis of himbacine analogs |
| 08/19/2009 | CN101511816A An aminoisoquinoline thrombin inhibitor with improved bioavailability |
| 08/19/2009 | CN101511815A New pyridine analogues |
| 08/19/2009 | CN101511792A New pyridine analogues |
| 08/19/2009 | CN101511367A Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifying agent |
| 08/19/2009 | CN101508993A Bullfrog lectin gene, encoded lectin and uses thereof |
| 08/19/2009 | CN101508983A Method for separation and purification of natto kinase by using soybean particle as affinity matrix |
| 08/19/2009 | CN101508739A Radio frequency auxiliary method for extracting glossy ganoderma seed polysaccharide |
| 08/19/2009 | CN101508734A Anti-CD40 monoclonal antibody |
| 08/19/2009 | CN101508724A Method of preparing tetradecapeptide somatostatin |
| 08/19/2009 | CN101508685A Improved preparation method for cinepazide maleate |
| 08/19/2009 | CN101508684A Synthesis of cinepazide maleate |
| 08/19/2009 | CN101507786A Compound traditional Chinese medicine active constitutes capable of improving erythrocyte deformability and preparation method thereof |
| 08/19/2009 | CN101507761A Traditional Chinese medicine composite for treating horse chronic hydrocephalus |
| 08/19/2009 | CN101507738A Preparation method of Shu Xuening injection |
| 08/19/2009 | CN101507712A Sustained-release micro-spheres preparation containing recombined erythropoietin and preparation method and use thereof |
| 08/19/2009 | CN100528898C High purity ulinastatin and its prepn process and medicine composition |
| 08/19/2009 | CN100528834C Pharmaceutical compounds |
| 08/19/2009 | CN100528237C Preparation of polynuclear iron hydroxide-sugar composite |
| 08/19/2009 | CN100528235C Conjugates of erythropoietin |
| 08/19/2009 | CN100528203C Dragon's blood dropping pill and its preparing process |
| 08/19/2009 | CN100528157C Form of presentation for 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino] propionic acid ethyl ester to be administered oral |
| 08/19/2009 | CN100528149C A composition for treating neurocerebrovascular disorders |
| 08/19/2009 | CN100528148C Oil-in-water type nanometer peonol emulsion oral liquid and its preparation process |
| 08/19/2009 | CN100528141C Freeze dried ligustrazine hydrochloride preparation for injection and its preparation process |
| 08/18/2009 | US7576234 Synthesis of 2-alkyl amino acids |
| 08/18/2009 | US7576115 1-methyl,3-alkaminothiocarbonylhydrazonomethyl,4-hydroxy,5-phenyl pyrazole; low-molecular-weight, nonpeptidic thrombopoietin receptor agonist; oral administration; bioavailability; blood disorders; platelet-increasing agents; angiogenesis; arteriosclerosis; blood/stem cell stimulant; thrombocytopenia |
| 08/18/2009 | US7576111 Substituted oxazolidinones and their use in the field of blood coagulation |
| 08/18/2009 | US7575872 An antibody specific for von Willebrand factor specific cleaving enzyme (hereinafter also referred to as ADAMTS-13), which can be obtained from a warm-blooded animal immunized and sensitized with a polypeptide containing a part or the whole of ADAMTS-13 amino acid sequence |
| 08/18/2009 | CA2577233C Pharmaceutical composition containing angiotensin ii antagonist |
| 08/18/2009 | CA2369444C Pharmaceutical compositions of erythropoietin |
| 08/18/2009 | CA2215697C Stable polymerized hemoglobin blood-substitute |
| 08/18/2009 | CA2174526C Pseudodipeptide product possessing an imidazole group and the therapeutic, cosmetological and agri-food applications of the said product |
| 08/13/2009 | WO2009099377A1 Treatment of idiopathic thrombocytopenic purpura |
| 08/13/2009 | WO2009098142A1 Prasugrel salts with improved properties |
| 08/13/2009 | WO2009097973A2 Imidazopyridazines as par1 inhibitors, production thereof, and use thereof as medicaments |
| 08/13/2009 | WO2009097972A1 Sf5 derivatives as par1 inhibitors, production thereof, and use as medicaments |
| 08/13/2009 | WO2009097971A1 Triazolium salts as par1 inhibitors, production thereof, and use as medicaments |